AOD-9604 5mgAOD-9604 5mg
AOD-9604 5mg is supplied in a branded pre-filled pen with case, available only following an online consultation and clinician approval.
Answer a short online consultation. A clinician reviews it, and you only pay if treatment is approved. Dispensed by our licensed facility.
What it is
AOD-9604 is a synthetic, modified fragment of human growth hormone corresponding to amino acids 177–191. It is not the same as full-length human growth hormone, and findings about growth hormone cannot be assumed to apply to this fragment.
The 5mg label describes the product presentation, not an individual prescribing recommendation. The branded pre-filled pen and case are packaging features; they do not establish clinical effectiveness or regulatory approval.
Why people ask about it
People often ask about AOD-9604 after encountering online discussions about body composition, fat metabolism or healthy ageing. These discussions can give a stronger impression of benefit than the available evidence supports.
A consultation provides an opportunity to review those expectations, discuss established alternatives and consider whether any prescription is appropriate. An enquiry does not guarantee clinician approval.
What the science says
Much of the interest in AOD-9604 comes from laboratory and animal findings. Human weight-management studies have also been conducted, but they have not established consistent, clinically meaningful effectiveness. Findings from experimental models do not demonstrate benefits for people.
Evidence is particularly limited for long-term use and for the specific branded pre-filled pen presentation. There is no robust clinical evidence that AOD-9604 extends lifespan or improves healthy ageing outcomes.
Is it right for me?
AOD-9604 is not appropriate for people under 18 or during pregnancy or breastfeeding, given the absence of adequate safety evidence. Anyone with a known allergy to an ingredient should not receive it.
Active cancer or a history of cancer requires particular caution and specialist input; safety in these circumstances has not been established. Our clinicians review medical history, current medicines and relevant health concerns before deciding whether prescribing is appropriate. They may decline a prescription or recommend further assessment.
How Welcuren works
Complete a short online consultation about your health and goals.
A clinician reviews your answers, may ask follow-up questions, and decides whether this treatment is appropriate for you.
You only pay once treatment is approved. Our licensed facility then dispatches it with full instructions, on tracked global delivery.
Safety
The side-effect profile of AOD-9604 is not well characterised, particularly over the long term. Possible concerns include local skin reactions and allergic reactions, but their frequency and severity are uncertain. Limited published data should not be interpreted as reassurance that the product is risk-free.
Our clinicians discuss uncertainties, review relevant medicines and arrange follow-up where appropriate. Monitoring cannot eliminate unknown risks. Any new or concerning symptoms should be reported promptly; breathing difficulty or swelling of the face or throat requires urgent medical attention.
Questions
Is AOD-9604 licensed in the UK?
AOD-9604 does not have UK marketing authorisation as a medicine. Supply through our licensed facility does not mean the product itself is licensed or that its effectiveness has been established. Our clinicians explain its unlicensed status before any prescribing decision.
Is AOD-9604 proven to support weight loss or longevity?
No reliable, clinically meaningful weight-loss benefit has been established in human trials. There is also no robust clinical evidence supporting longevity benefits. Laboratory and animal findings are not proof of outcomes in people.
What is supplied?
The product is supplied as an AOD-9604 5mg branded pre-filled pen with case. The 5mg description identifies the presentation and is not an individual prescribing recommendation.
Can I order without a consultation?
No. A prescription is considered only after an online consultation and clinician approval. Our clinicians assess suitability, explain evidence and safety limitations, and may decide that prescribing is not appropriate.
This information is educational and not a substitute for advice from your clinician. Prescription treatments are only supplied after a clinical consultation.
Often considered together
Many clients start with a blood test so their clinician has a full picture.
CJC-1295 + Ipamorelin BlendCJC-1295 + Ipamorelin Blend
A dual-secretagogue blend with uncertain formulation and no robust clinical evidence for the marketed combination.
CJC-1295 No DAC 5mgCJC-1295 No DAC 5mg
A label commonly used for modified GRF(1–29), distinct from the albumin-binding CJC-1295 studied in published trials.
CJC-1295 with DAC 2mgCJC-1295 with DAC 2mg
An albumin-binding GHRH analogue studied in small human trials for hormonal responses, not proven wellness outcomes.